Back to Search Start Over

Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates

Authors :
Vladimir P. Baklaushev
P. A. Mel’nikov
V. A. Kalsin
I. L. Gubskiy
Oleg V Durov
Ekaterina M Samoilova
Dzhina D Karal-Ogly
Sergey V Kim
A. V. Troitskiy
S. V. Orlov
Jan-Eric Ahlfors
Eugene V Gulaev
Vladimir P. Chekhonin
V. A. Revkova
Alexander Averyanov
Source :
World Journal of Stem Cells
Publication Year :
2021
Publisher :
Baishideng Publishing Group Inc., 2021.

Abstract

BACKGROUND The development of regenerative therapy for human spinal cord injury (SCI) is dramatically restricted by two main challenges: the need for a safe source of functionally active and reproducible neural stem cells and the need of adequate animal models for preclinical testing. Direct reprogramming of somatic cells into neuronal and glial precursors might be a promising solution to the first challenge. The use of non-human primates for preclinical studies exploring new treatment paradigms in SCI results in data with more translational relevance to human SCI. AIM To investigate the safety and efficacy of intraspinal transplantation of directly reprogrammed neural precursor cells (drNPCs). METHODS Seven non-human primates with verified complete thoracic SCI were divided into two groups: drNPC group (n = 4) was subjected to intraspinal transplantation of 5 million drNPCs rostral and caudal to the lesion site 2 wk post injury, and lesion control (n = 3) was injected identically with the equivalent volume of vehicle. RESULTS Follow-up for 12 wk revealed that animals in the drNPC group demonstrated a significant recovery of the paralyzed hindlimb as well as recovery of somatosensory evoked potential and motor evoked potential of injured pathways. Magnetic resonance diffusion tensor imaging data confirmed the intraspinal transplantation of drNPCs did not adversely affect the morphology of the central nervous system or cerebrospinal fluid circulation. Subsequent immunohistochemical analysis showed that drNPCs maintained SOX2 expression characteristic of multipotency in the transplanted spinal cord for at least 12 wk, migrating to areas of axon growth cones. CONCLUSION Our data demonstrated that drNPC transplantation was safe and contributed to improvement of spinal cord function after acute SCI, based on neurological status assessment and neurophysiological recovery within 12 wk after transplantation. The functional improvement described was not associated with neuronal differentiation of the allogeneic drNPCs. Instead, directed drNPCs migration to the areas of active growth cone formation may provide exosome and paracrine trophic support, thereby further supporting the regeneration processes.

Details

ISSN :
19480210
Volume :
13
Database :
OpenAIRE
Journal :
World Journal of Stem Cells
Accession number :
edsair.doi.dedup.....527730bd0cdc93f54775c2933118f2d1
Full Text :
https://doi.org/10.4252/wjsc.v13.i5.452